The invention concerns a product inhibiting transduction of G heterotrimeric protein signals combined with another anti-cancer agent, in particular farnesyltransferase inhibitors, taxol or gemcitabin, for simultaneous, separate or prolonged therapeutic use in cancer treatment.

 
Web www.patentalert.com

< Method of preparing amine stereoisomers

< Proteins and nucleic acids encoding same

> Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein

> Substituted quinazolinone compounds
~ 00256